While until recently the rule was to initiate beta-blocker therapy only when varices occurred, it has recently been recommended to prescribe beta-blockers early and regardless of the stage of the varices. This treatment strategy has been shown to improve long-term survival and reduce the risk of decompensation events. In patients with already decompensated liver cirrhosis, there is a survival advantage if the TIPS (transjugal intrahepatic portosystemic shunt) is placed early in secondary prophylaxis.
You May Also Like
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies
Advances in breast cancer therapy in the age of molecular diagnostics
- Current overview of evidence, mechanisms and clinical implications
Apolipoprotein E and neuropsychiatric symptoms in neurocognitive disorders
- Parkinson's disease
Individual therapy management for an optimized outcome – an update
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Latent autoimmune diabetes in adults (LADA)
Looks like type 2, but is type 1
- Treatment of vitiligo